COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type

By sjmartinez • October 10, 2024

Hilser JR, Spencer NJ, Afshari K, Gilliland FD, Hu H, Deb A, Lusis AJ, Wilson Tang WH, Hartiala JA, Hazen SL, Allayee H. COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type. Arterioscler Thromb Vasc Biol. 2024 Oct 9. doi: 10.1161/ATVBAHA.124.321001. Epub ahead of print. PMID: 39381876.

Tags: Cardiology/Epi, covid-19, genetics, major adverse cardiac events, myocardial infarction, Publications, SARS-CoV-2, stroke, Thrombosis

Association Between Colchicine Use and Clinical Outcomes Post Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials

Jaiswal V, Hanif M, Raja HAA, Khadka S, Deb N, Mashkoor Y, Ahmed A, Rajak K, Jaiswal AK, Gupta M, Hirji S, Fonarow GC, Qamar[...]

A Multicenter Randomized Controlled Trial of a Digital Health Intervention for Medication Optimization in Heart Failure: The ENGAGE-HF Trial Outcomes

Dorsch MP, Gilotra NA, Spaulding EM, Martin SS, Zhao H, Wilson GA, Poddar M, Verma A, Schmiedmayer P, Kraft P, Rodriguez F, Azizi Z, Hwang[...]

Digital Health Intervention to Optimize Heart Failure Management After Hospital Discharge in Brazil (OPT-HF): A Randomized Clinical Trial

Ciminelli ALA, Sandhu AT, Longenecker CT, Rezende LC, Camelo LV, Gonçalves BPA, Lino RZS, Bramucci V, Melo BMH, Siqueira CV, Carvalho APV, Ribeiro EG, Ferreira[...]